UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 190

Sortiert nach

Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma

Annals of hematology, 2014-03, Vol.93 (3), p.403-409

2014

Volltextzugriff (PDF)

Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2011-06, Vol.29 (16), p.2191-2198

2011

Volltextzugriff (PDF)

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Journal of clinical oncology, 2015-05, Vol.33 (13), p.1475-1481

2015

Volltextzugriff (PDF)

A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea

Cancer, 2014-02, Vol.120 (4), p.513-520

2014

Volltextzugriff (PDF)

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

Journal of clinical oncology, 2010-11, Vol.28 (33), p.4877-4883

2010

Volltextzugriff (PDF)

A Phase I Single-Agent Study of Twice-Weekly Consecutive-Day Dosing of the Proteasome Inhibitor Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma or Lymphoma

Clinical cancer research, 2012-09, Vol.18 (17), p.4830-4840

2012

Volltextzugriff (PDF)

A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2013-10, Vol.72 (4), p.861-868

2013

Volltextzugriff (PDF)

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Clinical cancer research, 2018-12, Vol.24 (24), p.6150-6159

2018

Volltextzugriff (PDF)

Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study

Journal of clinical oncology, 2011-09, Vol.29 (25), p.3389-3395

2011

Volltextzugriff (PDF)

A Phase Ib Study of AMG 102 in Combination with Bevacizumab or Motesanib in Patients with Advanced Solid Tumors

Clinical cancer research, 2010-05, Vol.16 (9), p.2677-2687

2010

Volltextzugriff (PDF)

A Multicenter, Phase 2 Study of Vascular Endothelial Growth Factor Trap (Aflibercept) in Platinum- and Erlotinib-Resistant Adenocarcinoma of the Lung

Journal of thoracic oncology, 2010-07, Vol.5 (7), p.1054-1059

2010

Volltextzugriff (PDF)

Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis

Cancer, 2001-09, Vol.92 (6), p.1368-1377

2001

Volltextzugriff (PDF)

A Phase I Study of Cetuximab/Paclitaxel in Patients with Advanced-Stage Breast Cancer

Clinical breast cancer, 2006-08, Vol.7 (3), p.270-277

2006

Volltextzugriff (PDF)

Disseminated Intravascular Coagulation Secondary to Advanced Pancreatic Cancer Treated Successfully with Combination Chemotherapy

Oncology, 2014-01, Vol.87 (5), p.266-269

2014

Volltextzugriff (PDF)

A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors

Oncotarget, 2015-07, Vol.6 (21), p.18693-18706

2015

Volltextzugriff (PDF)

Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2014-01, Vol.9 (1), p.121-125

2014

Volltextzugriff (PDF)

Mammary angiosarcoma: The prognostic significance of tumor differentiation

Cancer, 1988-11, Vol.62 (10), p.2145-2151

1988

Volltextzugriff (PDF)

A phase II trial of irinotecan in hormone-refractory prostate cancer

Investigational new drugs, 1998, Vol.16 (4), p.353-359

1998

Volltextzugriff (PDF)

BRCA-associated breast cancer in young women

Journal of clinical oncology, 1998-05, Vol.16 (5), p.1642-1649

1998

Volltextzugriff (PDF)

The clinical significance of pre-invasive breast carcinoma

Cancer, 1980-08, Vol.46 (4 Suppl), p.919-925

1980

Volltextzugriff (PDF)

Phase II trial of irinotecan in combination with amifostine in patients with advanced colorectal carcinoma

Cancer, 2002-04, Vol.94 (8), p.2174-2179

2002

Volltextzugriff (PDF)

Does clearing of axillary lymph nodes contribute to accurate staging of breast carcinoma?

Cancer, 1984-03, Vol.53 (6), p.1329-1332

1984

Volltextzugriff (PDF)

BRCA-associated breast cancer : Absence of a characteristic immunophenotype

Cancer research (Chicago, Ill.), 1998-05, Vol.58 (9), p.1839-1842

1998

Volltextzugriff (PDF)

A phase II trial of CI-921 in advanced malignancies

Investigational new drugs, 1992-11, Vol.10 (4), p.309-312

1992

Volltextzugriff (PDF)

p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis

Journal of clinical oncology, 1995-04, Vol.13 (4), p.821-830

1995

Volltextzugriff (PDF)

1 – 25 von 190

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(182)
Mit Volltextzugriff
(181)

Publikationsform

Artikel
(190)

Sprache

Englisch
(190)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma

Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

A Phase I Single-Agent Study of Twice-Weekly Consecutive-Day Dosing of the Proteasome Inhibitor Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma or Lymphoma

A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumors

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study

A Phase Ib Study of AMG 102 in Combination with Bevacizumab or Motesanib in Patients with Advanced Solid Tumors

A Multicenter, Phase 2 Study of Vascular Endothelial Growth Factor Trap (Aflibercept) in Platinum- and Erlotinib-Resistant Adenocarcinoma of the Lung

Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis

A Phase I Study of Cetuximab/Paclitaxel in Patients with Advanced-Stage Breast Cancer

Disseminated Intravascular Coagulation Secondary to Advanced Pancreatic Cancer Treated Successfully with Combination Chemotherapy

A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors

Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer

Mammary angiosarcoma: The prognostic significance of tumor differentiation

A phase II trial of irinotecan in hormone-refractory prostate cancer

BRCA-associated breast cancer in young women

The clinical significance of pre-invasive breast carcinoma

Phase II trial of irinotecan in combination with amifostine in patients with advanced colorectal carcinoma

Does clearing of axillary lymph nodes contribute to accurate staging of breast carcinoma?

BRCA-associated breast cancer : Absence of a characteristic immunophenotype

A phase II trial of CI-921 in advanced malignancies

p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis

Aktive Filter

Suchergebnisse filtern